Earnings calendar/CTMX
CytomX Therapeutics, Inc. (CTMX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.09
Street estimate
Revenue target
$10.4M
Street estimate
Trailing EPS (avg 4Q)
$-0.13
Beat rate last 4: 25%
Latest EPS YoY
-7400.0%
vs 2025-08-07
Latest revenue YoY
-92.4%
How results look so far
Trailing revenue (avg 4Q)
$4.6M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.09 / $-0.08
-16.7%
Revenue actual / est
$1.4M / $12.4M
-88.6%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.09 | Pending | — | $10.4M | Pending | — |
| 8/6/2026 | $-0.08 | $-0.09 | -16.7% | $12.4M | $1.4M | -88.6% |
| 5/11/2026upcoming | $-0.14 | Pending | — | $4.7M | Pending | — |
| 5/7/2026 | $-0.14 | $-0.10 | +28.6% | $4.7M | $10.3M | +119.1% |
| 3/16/2026 | $-0.08 | $-0.22 | -175.0% | $7.3M | $661,000 | -91.0% |
| 3/5/2026upcoming | $-0.08 | Pending | — | $7.3M | Pending | — |
| 11/6/2025 | $-0.05 | $-0.09 | -82.6% | $7.3M | $6.0M | -18.6% |
| 8/7/2025 | $-0.06 | $-0.00 | +98.1% | $18.3M | $18.7M | +2.1% |
| 5/12/2025 | $0.12 | $0.27 | +116.3% | $35.4M | $50.9M | +43.7% |
| 3/6/2025 | $-0.23 | $0.22 | +195.7% | $13.0M | $38.1M | +192.1% |
| 11/7/2024 | $-0.17 | $0.07 | +141.2% | $13.5M | $33.4M | +147.0% |
| 8/8/2024 | $-0.14 | $-0.08 | +42.9% | $20.0M | $25.1M | +25.6% |
| 5/8/2024 | $-0.08 | $0.17 | +312.5% | $21.4M | $41.5M | +93.5% |
| 3/11/2024 | $-0.03 | $0.01 | +133.3% | $19.6M | $26.6M | +35.8% |
| 11/7/2023 | $-0.19 | $0.04 | +121.1% | $20.4M | $26.4M | +29.3% |
| 8/8/2023 | $-0.20 | $-0.02 | +90.0% | $13.9M | $24.7M | +78.1% |
| 5/9/2023 | $-0.11 | $-0.05 | +54.9% | $19.6M | $23.5M | +20.0% |
| 3/27/2023 | $-0.24 | $-0.43 | -79.2% | $17.9M | $20.1M | +12.7% |
| 11/8/2022 | $-0.31 | $-0.35 | -12.9% | $18.2M | $11.1M | -38.6% |
| 8/4/2022 | $-0.36 | $-0.37 | -2.8% | $18.1M | $12.9M | -29.0% |
| 5/5/2022 | $-0.36 | $-0.37 | -2.8% | $21.2M | $9.0M | -57.4% |
| 3/1/2022 | $-0.28 | $-0.40 | -42.9% | $19.6M | $19.7M | +0.8% |
| 11/4/2021 | $-0.31 | $-0.35 | -12.9% | $17.4M | $17.6M | +1.0% |
| 8/5/2021 | $-0.32 | $-0.30 | +6.3% | $16.3M | $16.3M | 0.0% |
| 5/6/2021 | $-0.35 | $-0.26 | +25.7% | $20.1M | $16.0M | -20.5% |
| 2/24/2021 | $-0.50 | $-0.32 | +36.0% | $22.3M | $16.4M | -26.5% |
| 11/5/2020 | $-0.48 | $-0.32 | +33.3% | $26.7M | $17.8M | -33.3% |
| 8/6/2020 | $0.16 | $-0.34 | -312.5% | $7.8M | $16.6M | +112.5% |
| 5/7/2020 | $-0.46 | $0.26 | +156.5% | $87.7M | $49.6M | -43.5% |
| 2/27/2020 | $-0.47 | $-0.78 | -66.0% | $7.0M | $8.3M | +18.7% |
| 11/7/2019 | $-0.51 | $-0.52 | -2.0% | $10.5M | $10.7M | +2.0% |
| 8/7/2019 | $-0.57 | $-0.64 | -12.3% | $8.0M | $9.0M | +12.3% |
| 5/9/2019 | $-0.53 | $-0.31 | +41.5% | $50.4M | $29.5M | -41.5% |
| 2/27/2019 | $-0.48 | $-0.72 | -50.0% | $7.6M | $11.5M | +50.0% |
| 11/6/2018 | $-0.44 | $-0.53 | -20.5% | $10.4M | $12.5M | +20.5% |
| 8/8/2018 | $-0.32 | $-0.35 | -9.4% | $19.5M | $21.3M | +9.4% |
| 5/9/2018 | $-0.44 | $-0.40 | +9.1% | $15.6M | $14.2M | -9.1% |
| 3/7/2018 | $-0.43 | $0.02 | +104.7% | $415.1M | $27.1M | -93.5% |
| 11/7/2017 | $-0.17 | $-0.28 | -64.7% | $21.1M | $24.1M | +14.5% |
| 8/7/2017 | $-0.37 | $-0.69 | -86.5% | $6.6M | $8.8M | +32.9% |
| 5/5/2017 | $-0.51 | $-0.23 | +54.9% | $25.8M | $11.7M | -54.9% |
| 3/2/2017 | $-0.43 | $-0.39 | +9.3% | $6.9M | $6.3M | -9.3% |
| 11/3/2016 | $-0.35 | $-0.40 | -14.3% | $3.0M | $3.5M | +14.3% |
| 8/3/2016 | $-0.41 | $-0.39 | +4.9% | $3.3M | $3.1M | -4.9% |
| 5/6/2016 | $-0.26 | $-0.44 | -69.2% | $2.0M | $2.2M | +12.2% |
| 3/7/2016 | $-0.34 | $-0.39 | -14.7% | $1.7M | $2.0M | +14.7% |
| 11/23/2015 | $-0.25 | $-14.26 | -5604.0% | $96.1M | $1.9M | -98.0% |
| 10/14/2015 | — | $-0.17 | — | — | $2.0M | — |
| 3/31/2015 | — | $-0.18 | — | — | $1.7M | — |
| 12/31/2014 | — | $-0.14 | — | — | $1.9M | — |
| 9/30/2014 | — | $-0.10 | — | — | $1.9M | — |
| 6/30/2014 | — | $-6.63 | — | — | $666,000 | — |
| 3/31/2014 | — | $-18.26 | — | — | $635,000 | — |
Need CTMX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.